|
|
| (11) | Liudijimo numeris | C 2203431 |
| (68) | Patento numeris | 2203431 |
| (21) | Paraiškos papildomos apsaugos liudijimui gauti numeris | PA 2015 013 |
| (22) | Paraiškos papildomos apsaugos liudijimui gauti padavimo data | 2015-03-04 |
| (41) | Paraiškos papildomos apsaugos liudijimui gauti paskelbimo data | 2015-04-27 |
| Liudijimo paskelbimo data | 2017-01-25 | |
| (24) | Liudijimo įsigaliojimo data | 2028-09-18 |
| (71) |
AbbVie Bahamas Limited,
Sassoon House, Shirley Street & Victoria Avenue, New Providence, Nassau,
BS
|
| (73) |
AbbVie Manufacturing Management Unlimited Company ,
70 Sir John Rogerson's Quay, Dublin 2,
IE
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (93) | EU/1/14/983, 2015-01-15 |
| (94) | 2030-01-19 |
| (95) | Dasabuviras |
| PAL panaikintas (nesumokėtas pagrindinio patento metų mokestis) | ||
| Panaikinimo data | 2025-09-17 |